AU2002224770A1 - Improved protocol for paracentesis - Google Patents

Improved protocol for paracentesis

Info

Publication number
AU2002224770A1
AU2002224770A1 AU2002224770A AU2477002A AU2002224770A1 AU 2002224770 A1 AU2002224770 A1 AU 2002224770A1 AU 2002224770 A AU2002224770 A AU 2002224770A AU 2477002 A AU2477002 A AU 2477002A AU 2002224770 A1 AU2002224770 A1 AU 2002224770A1
Authority
AU
Australia
Prior art keywords
paracentesis
improved protocol
protocol
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224770A
Inventor
Didier Lebrec
Richard Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2002224770A1 publication Critical patent/AU2002224770A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
AU2002224770A 2000-09-15 2001-09-17 Improved protocol for paracentesis Abandoned AU2002224770A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00402558 2000-09-15
EP00402558A EP1188443A1 (en) 2000-09-15 2000-09-15 Improved protocol for paracentesis
PCT/EP2001/011313 WO2002024213A2 (en) 2000-09-15 2001-09-17 Improved protocol for paracentesis

Publications (1)

Publication Number Publication Date
AU2002224770A1 true AU2002224770A1 (en) 2002-04-02

Family

ID=8173863

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224770A Abandoned AU2002224770A1 (en) 2000-09-15 2001-09-17 Improved protocol for paracentesis

Country Status (4)

Country Link
US (1) US7160853B2 (en)
EP (2) EP1188443A1 (en)
AU (1) AU2002224770A1 (en)
WO (1) WO2002024213A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960336B2 (en) * 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8563527B2 (en) 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
WO2009045309A2 (en) * 2007-09-28 2009-04-09 Ferring B.V. Use of v2 receptor antagonists in combination with vasopressinergic agonists
JO3109B1 (en) * 2012-05-10 2017-09-20 Ferring Bv V1a receptor agonists
CN114028536A (en) 2014-10-24 2022-02-11 马林克罗特医疗产品知识产权公司 Method of treating patients with hepatorenal syndrome type 1
US9388214B2 (en) 2014-11-05 2016-07-12 Ferring B.V. V1A receptor agonists
JP2017014206A (en) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド Treatment of ascites
CN105301156B (en) * 2015-10-12 2017-05-24 天津红日药业股份有限公司 Related substance analysis method for terlipressin for injection
US10993984B2 (en) 2016-10-21 2021-05-04 Chiasma, Inc. Terlipressin compositions and their methods of use
AU2020279395A1 (en) * 2019-05-22 2021-12-16 Biovie Inc. Formulations of terlipressin
CN114177147B (en) * 2021-12-15 2023-05-23 福建省闽东力捷迅药业股份有限公司 Preparation method of terlipressin for injection and terlipressin for injection prepared by preparation method

Also Published As

Publication number Publication date
WO2002024213A2 (en) 2002-03-28
EP1188443A1 (en) 2002-03-20
US20040102362A1 (en) 2004-05-27
US7160853B2 (en) 2007-01-09
EP1320378A2 (en) 2003-06-25
WO2002024213A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001262480A1 (en) Protocol stacks
AU2001236970A1 (en) Packet processor
AU2001269086A1 (en) Substitution-box for symmetric-key ciphers
AU2001288028A1 (en) Virtual neuro-psychological testing protocol
AU2001262847A1 (en) Language-understanding
AU6143700A (en) Split-key key-agreement protocol
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001291783A1 (en) Encryption
AU6095000A (en) Generic sbe-fret protocol
AU2001258349A1 (en) Bisacylguanidine
AU2002223503A1 (en) Decondenser unit
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2002224770A1 (en) Improved protocol for paracentesis
AU2001258924A1 (en) Microsatellite-aflp
AU2001254731A1 (en) Substituted phenyluracils
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001220281A1 (en) Rollerboard for road-skiing
EP1185135A3 (en) Chinguard for headphone
AU2001246864A1 (en) Hypotensors
AU2001231107A1 (en) Improved lactational
AU2002214354A1 (en) Neck-phone
AU2001259141A1 (en) Protocol for secure communications